Anke Ohler
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 8
-
- Protease and Inhibitor Mechanisms 7
- Co-authors
- Christoph Becker‐Pauly (9 shared papers)Viktor Magdolen (2 shared papers)Christopher M. Overall (2 shared papers)Ulrich auf dem Keller (2 shared papers)Claudia Broder (2 shared papers)Claus U. Pietrzik (5 shared papers)Mekdes Debela (1 shared paper)Reinhild Kappelhoff (1 shared paper)
In The Last Decade
Anke Ohler
17 papers receiving 520 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 261
- Pathology and Forensic Medicine 56
- Physiology 66
- Neurology 20
- Aging 4
Countries citing papers authored by Anke Ohler
This map shows the geographic impact of Anke Ohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Ohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Ohler more than expected).
Fields of papers citing papers by Anke Ohler
This network shows the impact of papers produced by Anke Ohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Ohler. The network helps show where Anke Ohler may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Ohler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 116 | |
| 2 | 2012 | 115 | |
| 3 | 2010 | 68 | |
| 4 | 2022 | 40 | |
| 5 | 2015 | 34 | |
| 6 | 2022 | 34 | |
| 7 | 2016 | 31 | |
| 8 | 2012 | 23 | |
| 9 | 2024 | 14 | |
| 10 | 2011 | 13 | |
| 11 | 2020 | 12 | |
| 12 | 2022 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 3 | |
| 16 | 2023 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Anke Ohler
Anke Ohler is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Neurology and Statistics and Probability, having authored 20 papers that have together received 532 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Protease and Inhibitor Mechanisms (7 papers), CAR-T cell therapy research (3 papers), COVID-19 and healthcare impacts (1 paper), COVID-19 Clinical Research Studies (1 paper), Zebrafish Biomedical Research Applications (1 paper), Alzheimer's disease research and treatments (1 paper) and Barrier Structure and Function Studies (1 paper). The work is most often cited by research in Cancer Research (261 citations), Pathology and Forensic Medicine (56 citations), Physiology (66 citations), Neurology (20 citations) and Aging (4 citations). Anke Ohler has collaborated with scholars based in Germany, Italy and Sweden. Frequent co-authors include Christoph Becker‐Pauly, Viktor Magdolen, Christopher M. Overall, Ulrich auf dem Keller, Claudia Broder, Claus U. Pietrzik, Mekdes Debela, Reinhild Kappelhoff, Oliver Schilling and Walter Stöcker. Their work appears in journals such as Biological Chemistry, Blood, Cellular and Molecular Life Sciences, HemaSphere and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.